7/2/2019
`
`Press Release | Newsroom | Medtronic
`CASE 0:19-cv-01760 Document 1-4 Filed 07/02/19 Page 1 of 2
`
`Print Page(cid:124)(cid:124)Close Window
`
`PRESS RELEASE
`
`Medtronic Launches Telescope(TM) Guide Extension Catheter to Support Complex Coronary Cases
`p
`
`FDA Cleared and CE Marked, Telescope Enters Global Market with Design Innovations to Enable Smooth Delivery
`
`of Coronary Stents and Balloons
`DUBLIN - May 16, 2019 - Medtronic plc (NYSE:MDT), a global leader in percutaneous coronary intervention
`
`(PCI) innovation, today announced its entrance into the guide extension catheter market with the global
`
`launch of the Telescope(TM) Guide Extension Catheter, a newly designed catheter used to provide additional
`
`backup support and access to distal lesions. Guide extension catheters help deliver coronary stents,
`
`balloons and other interventional devices during angioplasty procedures that help to restore blood flow
`
`through the coronary and peripheral arteries.
`
`Developed alongside interventional cardiologists, many of whom are increasingly challenged with complex
`
`cases - such as patients with tortuous anatomies, calcified vessels, and distal lesions - the Telescope guide
`
`1
`extension catheter provides operators with superior deliverability and is designed to enable smooth
`
`delivery of interventional devices in more challenging cases.
`
`"It is not an exaggeration to say that guide extension technologies have greatly impacted the ability to
`
`deliver devices to the distal coronary vasculature, especially for cases where traditional guide support may
`
`be limited," said Ajay Kirtane, M.D., S.M., director of the NewYork-Presbyterian Hospital/Columbia University
`
`Cardiac Catheterization Laboratories. "In this light, the Telescope - a guide extension catheter with specific
`
`design optimizations aiming to stably deliver devices through tortuous anatomy - is a welcome addition to
`
`the interventional toolbox."
`
`The Telescope guide extension catheter combines a solid, round pushwire with a coil-reinforced hydrophilic-
`
`coated distal segment to help physicians reach challenging lesions with improved pushability and
`
`2
`deliverability. Telescope also features a flexible TruFlex(TM) soft polymer tip, which is designed to
`
`responsively bend and deflect during use. In addition, once Telescope is in position near the target lesion,
`
`SmoothPass technology helps to smoothly channel stents, balloons, and other interventional devices into
`
`place.
`
`"Before bringing this important technology to market, we collaborated with more than 700 interventional
`
`cardiologists to ensure Telescope was addressing unmet needs in complex PCI," said Dave Moeller, vice
`
`president and general manager of the Coronary and Renal Denervation business, which is part of the Cardiac
`EXHIBIT D
`
`newsroom.medtronic.com/phoenix.zhtml?c=251324&p=irol-newsArticle_Print&ID=2398888
`
`1/2
`
`
`Page 1
`
`Teleflex Ex. 2204
`Medtronic v. Teleflex
`
`

`

`7/2/2019
`
`Press Release | Newsroom | Medtronic
`CASE 0:19-cv-01760 Document 1-4 Filed 07/02/19 Page 2 of 2
`and Vascular Group at Medtronic. "We will continue to make investments in cutting edge interventional
`
`technologies, clinical evidence expansion, and robust physician training programs, which we believe will
`
`make a meaningful difference for physicians and their patients."
`
`In addition to the Telescope guide extension catheter, Medtronic's market-leading coronary portfolio
`
`includes the latest-generation Resolute Onyx(TM) Drug-Eluting Stent (DES), the Euphora(TM) line of pre-
`
`and post-dilatation balloon catheters, and a full suite of catheters including the DxTerity(TM) TRA
`
`Diagnostic Catheter and market-leading Launcher® Guide Catheter, all of which are commercially available
`
`in the U.S., as well as throughout Europe.
`About Medtronic
`
`(cid:124) Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical
`
`technology, services and solutions companies - alleviating pain, restoring health and extending life for
`
`millions of people around the world. Medtronic employs more than 86,000 people worldwide, serving
`
`physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with
`
`stakeholders around the world to take healthcare Further, Together.
`Any forward-looking statements are subject to risks and uncertainties such as those described in
`Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may
`differ materially from anticipated results.
`
`-end-
`
`(cid:124)(cid:124)
`
` (cid:124)
`(cid:124) (cid:124) (cid:124)
`Deliverability bench testing: Telescope(TM) GEC 6 F vs. GuideLiner(TM)* V3 5.5 F/6 F vs. Guidezilla(TM)* II 6F
`Bench test data. Bench test data may not be indicative of clinical performance.
`(cid:124) (cid:124) (cid:124)
`Deliverability bench testing: Telescope(TM) GEC 6 F vs. GuideLiner(TM)* V3 5.5 F/6 F vs. Guidezilla(TM)* II 6
`F. Pushability bench testing: Telescope(TM) GEC 6 F vs. GuideLiner(TM)* V3 6 F vs. Guidezilla(TM)* II 6 F.
`Bench test data may not be indicative of clinical performance.
`(cid:124) (cid:124)
`
`(cid:124) C
`
`ontacts:
`
`(cid:124) Joey Lomicky
`
`(cid:124) Public Relations
`
`(cid:124) +1-763-526-2494
`
`(cid:124)
`
`(cid:124) Ryan Weispfenning
`
`(cid:124) Investor Relations
`
`(cid:124) +1-763-505-4626
`
`newsroom.medtronic.com/phoenix.zhtml?c=251324&p=irol-newsArticle_Print&ID=2398888
`
`EXHIBIT D
`
`2/2
`
`
`Page 2
`
`Teleflex Ex. 2204
`Medtronic v. Teleflex
`
`